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Abstract: Tremor is a prominent phenotype of the twitcher mouse, an authentic genetic
model of Globoid-Cell Leukodystrophy (GLD, Krabbe’s disease). In the current study, the
tremor was quantified using a force-plate actometer designed to accommodate low-weight
mice. The actometer records the force oscillations caused by a mouse’s movements, and
the rhythmic structure of the force variations can be revealed. Results showed that twitcher
mice had significantly increased power across a broad band of higher frequencies
compared to wildtype mice. Bone marrow transplantation (BMT), the only available
therapy for GLD, worsened the tremor in the twitcher mice and induced a measureable
alteration of movement phenotype in the wildtype mice. These data highlight the damaging
effects of conditioning radiation and BMT in the neonatal period. The behavioral
methodology used herein provides a quantitative approach for assessing the efficacy of
potential therapeutic interventions for Krabbe’s disease.
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1. Introduction
Globoid-cell leukodystrophy (GLD; Krabbe’s disease) is a rapidly progressive demyelinating
disease caused by the deficiency of the lysosomal enzyme Galactosylceramidase (GALC) [1]. The
disease is characterized by prominent CNS symptoms including delayed development, spasticity, and
seizures. In humans, the age of onset of symptoms is usually around 6 months, with inevitable
progression and death by around 2–3 years of age. Currently, the only available treatment in humans is
bone marrow transplantation (BMT). Although BMT can be relatively effective if initiated in
pre-symptomatic patients, it is not a cure and treated children continue to develop clinical signs. One
important question is: are the continually progressing clinical signs due to GALC deficiency or are
they treatment-related?
The murine model used to study GLD is the twitcher mouse which is deficient in the same enzyme
as that of humans [2,3]. The eponymous and characteristic feature of the murine model is severe
twitching or tremor. Other phenotypic features include decreased body weight, hindlimb ataxia, decreased
mobility and a shortened lifespan. Similar to the human disease, the neuropathology consists of
demyelination, axonal damage [4,5] with prominent inflammation, and the accumulation of lipid-laden
macrophages (globoid-cells) throughout the CNS and the PNS. Although tremor is a prominent
phenotype in the twitcher mouse, it has not been thoroughly characterized. Also, little is known about
how the tremor is altered after various treatments, especially BMT following harsh conditioning
regimens. In the current study, a detailed phenotypic characterization of the tremor in the twitcher
mouse was performed using a force-plate actometer [6] that allowed recording of the movementrelated force generated by small (7–13 g) mice. The power spectra and the locomotor activity of the
twitcher mice were compared to the wildtype mice to reveal several important differences. The study
also evaluated the effect of BMT on tremor and locomotor activity in both the twitcher and wild type
mice. The results demonstrate that BMT and the harsh conditioning regimens associated with this
procedure can superimpose additional clinical defects on this already devastating disease.
2. Methods
2.1. Colony Maintenance
Galc+/− and wildtype mice on the C57BL/6J background were obtained from The Jackson
Laboratory (Bar Harbor, ME) and maintained under the supervision of M.S.S. at Washington
University School of Medicine. The galc−/− mice were obtained by galc+/− × galc+/− matings. The
galc genotype was determined by twitcher-specific PCR [7]. All animals were allowed ad libitum
access to food and water, except during brief (12-min or less) behavioral recording sessions. All
animal experiments were approved by Institutional Animal Care and Use Committee at Washington
University School of Medicine.
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2.2. BMT and Harmaline Injections
Neonatal pups were genotyped on day 2 or 3 and BMT was performed on post natal day 3 or 4. The
mice received 400 rads of total body irradiation from a 137Cs source. The animals received an
intravenous injection of 106 nucleated bone marrow cells from a sex-matched galc+/+, GFP (+)
donor [8] via the superficial temporal vein [9].
Harmaline (1-methoxy-3,4-dihydro-β-carboline, H1392, Sigma, St. Louis, MO) at a dose of 15 mg/kg
was injected intraperitoneally 12 min before the start of tremor monitoring on post natal day 36.
The nomenclature for the various treatment groups and the number of animals used in the study is
as follows: (a) Wt—untreated wildtype (n = 28), (b) Twi—untreated mutant (twitcher; n = 34), (c)
BmtWt—wildtype mice treated with BMT (n = 12), (d) BmtTwi—twitcher mice treated with BMT
(n = 7), (e) WtH—wildtype mice treated with harmaline (n = 11), (f) TwiH—twitcher mice treated
with harmaline (n = 8), (g) BmtWtH—BmtWt mice treated with harmaline (n = 11), and (h)
BmtTwiH—BmtTwi mice treated with harmaline (n = 7).
2.3. Bone Marrow Engraftment
Since the current study was an extension of the previous study (Reddy et al., 2011), and there was
an overlap in the animals that were used in the abovementioned study with the current study. The
engraftment levels from the various groups are described in results.
2.4. Force Plate Actometer
The design of the force plate actometer and the principles used in the design were described
previously [6]. For the current study a force-plate actometer was custom made to accommodate the
relatively low body weight and impaired force production capabilities of the untreated twitcher mice.
The mean weight of the twitcher mice at 36 days was 10.4 ± 1.6 g compared to 16.9 ± 1.8 g for
wildtype mice at this age. The custom-made actometer used a carbon fiber/nomex composite material
for the load plate, which weighed 57 g, was 3.2 mm thick and measured 24 cm × 24 cm. The sensing
area was 20 cm × 20 cm, and the cage that confined the mouse to the load plate was constructed of
6.4 mm-thick clear polycarbonate with inside dimensions of 20 cm long by 20 cm wide by 15 cm high.
A removable clear polycarbonate top was perforated with ventilation holes. The load plate was
supported by four Model 31a miniature strain gauge load cells purchased from Honeywell/Sensotec
(Columbus, Ohio). The load cells were calibrated to yield a force resolution of 0.2 gram-force.
2.5. Actometer Data Acquisition and Analysis
The animals were acclimated for at least 30 min in the same room prior to tremor monitoring. Data
recording was conducted between 2 p.m. and 6 p.m. For mice given harmaline, the drug or saline was
injected 12 min prior to recording. Data were collected for 6 min, but only the first minute, when
movement was maximal, was used for the tremor analyses. The recordings from the transducers were
collected at 100 samples/s. The 12-bit integer raw data files were acquired with a LabMaster interface
(Scientific Solutions, Mentor, Ohio) that was controlled by a DOS-based Free Pascal program
(http://www.freepascal.org). The data from the raw integer files were converted to text files and
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formatted by Free Pascal programs for further processing by commercially available software (see
Statistics section below). Custom written Free Pascal programs were used to calculate distance
traveled and the number of low mobility bouts (see below).
The following data were extracted from the raw data files [6]: (a) Fz—the net force exerted by the
animal at a particular 0.01-s “instant” was calculated as the sum forces on each of the four transducers
that supported the load plate. The digitized Fz data obtained at 100 samples/s for the first minute of the
recording session were formatted into 12 consecutive 5.00-s time series. Importantly, for the tremor
analyses the Fz time series data were expressed as a percent of each mouse’s body weight. This
normalization made it possible to compare the power spectra across genetic and treatment conditions
without potential confounding by the body weight differences. Each time series (Fz(t)) was Fourier
transformed using the fft function in MATLAB (The Mathworks, Inc., Natick, MA). A 500-point
Hanning time-domain data window was used. The resulting 12 power spectra were averaged together
to yield a single power spectrum for each mouse. The individual frequencies obtained after Fourier
transformation were plotted as a continuous function (power spectrum; see Figure 1C) after filtering
to retain frequencies between 2.5 and 30.0 Hz. (b) The bandwidth was defined as the difference
between the upper and lower limit of the frequencies where the power was half that of the maximum.
(c) The center frequency was calculated as the frequency co-ordinate of the vertical line bisecting the
bandwidth. (d) The frequency at peak power was taken as the frequency at which the power was at
its maximum. (e) Power between 13 and 20 Hz was obtained by integrating the area under the power
spectrum curve between 13 and 20 Hz. The aforementioned power spectrum variables (a–e) were
computed for each individual mouse, and these variables were then subjected to standard statistical
treatments (see below).
Although the tremor analyses were performed for the first minute of force-plate recordings, the
variables for tracking and quantifying the mouse’s horizontal movements in the actometer were based
on the entire 6-min session. (f) The X-Y position of the mouse on the force plate and (g) the distance
traveled by the animal was calculated using the principle of moments and by calculating distance
(in mm) between centers of force locations at successive time points 0.5 s apart, respectively [6]. The
X-Y locations of the animal at various time points were plotted as a function of time to obtain the (h)
trajectory of animal movement. (i) X-Y coordinates of the center of force as a function of time were
additionally used to identify a low mobility bout, which was defined in terms of a virtual circle with a
radius of 15.0 mm that was centered on the mouse as it moved across the load plate. When 5.00 s
elapsed without movement beyond the perimeter of the circle, a low mobility bout was tallied, and the
5.00-s time interval was reset to 0 in order to “look for” the next bout. This measure gives an
indication of a mouse’s proclivity to “stay in one place” regardless of the location of that place on the
load plate.
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Figure 1. Characterization of tremor in the Twi mice. Representative Fz time series
recording from a Wt mouse (A) and a Twi mouse (B) over 12 seconds (each series is
6 s). The X-axis represents time and the Y-axis represents force the vertical force variation
(Fz) recorded by the force plate actometer. A Fourier transformation performed on the Fz
time series data yields a power spectrum that shows how much power (variance) the Fz
variation contains at each frequency of oscillation. The power spectrum can then be further
analyzed to yield peak power, frequency at peak power, center frequency, and bandwidth.
These data are represented diagrammatically on a hypothetical power spectrum plot (C).
The averaged power spectrum (D) of the Twi mice (solid black line) was shifted towards
higher frequencies compared to the Wt mice (dashed gray line). The center frequency (E)
was significantly increased in the Twi (open circles) compared to the Wt mice (filled
squares). There was a significant increase in the band width (F) in the Twi compared to the
Wt group. The peak power (G), frequency at peak power (H) and the power between 13
and 20 Hz (I) were significantly increased in the Twi group compared to the Wt group. The
horizontal bars represent the mean and the error bars represent the SEM (*** p < 0.001,
** p < 0.01).
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2.6. Statistical Analyses
Systat (Systat Software Inc., Chicago, IL, USA) and Graphpad prism (Graphpad Software, Inc.,
La Jolla, CA) were used for generating graphs and performing statistical analyses. ANOVA or
Kruskal-Wallis tests were used to compare different groups, and post-hoc multiple comparisons were
done using Bonferroni tests.
3. Results
3.1. Tremor and Locomotion in Twitcher Mice
The qualitative differences in the Fz time series between the Wt and Twi mice are shown in
Figure 1A,B. A Fourier transform was applied to the Fz time series to obtain a power spectrum
(Figure 1C). The power spectra of different animals were further analyzed to obtain the peak power,
frequency of peak power, center frequency, and bandwidth (Figure 1C). The averaged power spectra
(Figure 1D) showed that the Twi mice had substantially higher power at higher frequencies compared
to the Wt mice. The center frequency and the bandwidth in the Twi group were significantly higher
than these variables for the Wt group (Figure 1E,F). The peak power (Figure 1G), frequency of peak
power (Figure 1H), and the integrated power between 13 and 20 Hz (Figure 1I) were significantly
increased in the Twi group compared to the Wt group (p < 0.001 for all three comparisons; t-test). The
data for the Wt group are indicative of normal movements without any visible tremor, whereas the Twi
mice exhibited the obvious tremor for which they are named. This analysis shows that the tremor of
the twitcher mice manifests itself as relatively broad band, high-frequency force oscillations while on
the force-plate.
Figure 2. Characterization of locomotor activity in the twitcher mouse. The movement
trajectory of representative Wt and Twi mice are shown in (A) and (B), respectively. Each
panel represents the movement of the mouse for duration of 1 min. The box in which each
movement trajectory is plotted represents the inside wall of the 20 cm × 20 cm cage that
confined the mouse to the load plate. Each point in the panel represents the XY location of
the mouse at a certain point of time. The total distance traveled during 6 min is shown
in (C). The total distance traveled by the Wt mice (filled squares) is significantly higher
than that of the Twi mice (open circles). The horizontal bars represent the mean and the
error bars represent the SEM (*** p < 0.001).
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The Twi group had decreased locomotion compared to that of the Wt group. Representative
trajectories of these two groups are shown in Figure 2A,B. The total distance traveled was significantly
lower in the Twi group compared to the Wt group (p < 0.001, t-test; Figure 2C).
One way to validate the tremor recorded by this newly developed actometer is by comparing it to a
relatively well accepted pharmacological tremor model (harmaline treatment) [10]. Therefore, the
tremor in the Twi mouse was compared to the tremor in the wildtype mice injected with harmaline
(WtH). Harmaline induces a characteristic narrow-band, near 12-Hz tremor. Comparison of the Twi
and the WtH animals revealed a robust between-group difference in the averaged power spectra
(Figure 3A). As quantified in terms of the mean of the center frequencies, the Twi mice (15.8 Hz) had
significantly higher values than the WtH group (12.2 Hz) (p < 0.001; Bonferroni test, Figure 3B). The
WtH group had a near-12.2 Hz narrow peak, and the bandwidth was significantly less than that of the
Twi group (p < 0.001; Bonferroni test, Figure 3C). There was no statistically significant difference
between the distance traveled and the number of low mobility bouts between the WtH and the
Twigroups (data not shown), probably because tremor-inducing doses of harmaline in intact animals
suppresses locomotion [10].
Interestingly, when twitcher mice were injected with harmaline (TwiH), there was a blunted
response with no statistically significant change in center frequency or bandwidth compared to the Twi
group (Figure 3B,C). In the WtH group, the peak power was significantly higher (p < 0.001;
Bonferroni test; Figure 3D) while frequency of peak power was significantly lower (p < 0.05;
Bonferroni test; Figure 3E) compared to the Twi group. There was no significant difference between
the TwiH and WtH groups with respect to the distance traveled or the number of low mobility bouts
(data not shown).
3.2. Effect of Treatment on Tremor
In order to directly assess the effect of myeloreductive conditioning and BMT on the power spectra,
tremor quantification was performed on both wildtype and twitcher mice that received BMT (BmtWt
versus BmtTwi). The engraftment in various groups is essentially as reported in the study by
Reddy et al., 2011. BmtWt group had a mean +/− standard error engraftment of 20.52 +/− 3.077,
BmtTwi group was at 12.1 +/− 1.9 and the AAVBMT group was 16.09 +/− 4.0. The engraftment level
in the untransplanted animals was less than 1%.
The BmtWt group had greater power in both the frequencies around 10–12 Hz and in the higher
frequencies in the 13–20 Hz range compared to the Wt group (Figure 4A). The BmtTwi group had
greater power in the near 10 Hz lower frequency range compared to the Twi group. The center
frequency of the BmtWt group was significantly increased compared to the Wt group (p < 0.01;
Bonferroni test; Figure 4B). The bandwidth variable (data not shown) did not indicate any significant
between-group effects. The peak power (Figure 4C) and the power between 13 and 20 Hz (Figure 4E)
was significantly increased in the BmtWt group compared to the Wt group but not in the BmtTwi
group compared to the Twi group. The frequency of peak power was not significantly different in the
BmtWt group compared to the Wt group (Figure 4D). There was no significant difference in the
frequency of peak power between the BmtTwi group and the Twi group (Figure 4D). The total
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distance traveled was significantly decreased (decrement in normal function) in the BmtWt group
compared to the Wt group (Figure 4F).
Figure 3. Comparison of the tremor of the Twi mice with that of the tremor induced
by harmaline. The average power spectrum (A) of the Twi mice (solid black line)
reflected a broadband tremor and that of the WtH mice (solid gray line) showed a
characteristic narrow band 12 Hz tremor. The response to harmaline was blunted in the
TwiH mice (dashed black line). The center frequency (B) and bandwidth (C) were
significantly increased in the Twi group (open circles) compared to the WtH group (filled
diamonds), which exhibited the expected characteristic narrow band tremor typically
induced by harmaline in mice. The peak power (D) was significantly increased in the WtH
group compared to the Twi group. The frequency at peak power was significantly
decreased in the WtH group compared to the Twi group. There was no significant
difference in the center frequency, bandwidth, peak power and the frequency of peak
power between the Twi and TwiH groups (plus symbols). Horizontal bars represent the
mean and the error bars represent the SEM (*** p < 0.001, ** p < 0.01 and * p < 0.05).
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Figure 4. Effect of BMT on power spectra. The averaged power spectrum (A) of the
BmtWt group (dashed gray line) is shifted upward and rightward compared to the Wt
group (solid gray line). Similarly, the averaged power spectrum in the BmtTwi group
(dashed black line) is shifted upward across a broad frequency band compared to the Twi
group (solid black line). The center frequency (B) was significantly increased in the
BmtWt group (open triangles) compared to the Wt group (filled squares). There was no
significant difference between the untreated mut (open circles) and BmtTwi groups (cross
marks) in the center frequency. The peak power (C), frequency of peak power (D) and the
power between 13 and 20 Hz (E) was significantly increased in the BmtWt group
compared to the Wt group. Compared to the Twi group, the BmtTwi group showed no
significant difference in the center frequency (B), peak power (C), frequency of peak
power (D) and power between 13 and 20 Hz (E). The distance traveled by the BmtWt
group was significantly decreased compared to the Wt group (F). The horizontal bars
represent the mean and the error bars represent SEM (*** p < 0.001, ** p < 0.01 and
* p < 0.05).
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3.3. Harmaline Response in BMT Animals
The BMT-treated animals that had additional higher frequencies in the averaged power spectra
were compared to mice that received harmaline after BMT (BmtWtH and BmtTwiH). Interestingly,
the mice in the BmtWtH group were more resistant to harmaline-induced tremors than the WtH group
(Figure 5A). The response to harmaline in the BmtTwiH group was similar to the TwiH group
(Figure 5A). The center frequency was higher and the bandwidth was broader in the BmtWtH group
compared to the WtH group (Figure 5B,C). The peak power was significantly lower in the BmtWtH
group compared to the WtH group (Figure 5D). There was no significant difference in the center
frequency, bandwidth and peak power between the TwiH and BmtTwiH groups (Figure 5B–D). There
was no significant difference in the distance traveled or in the number of low mobility bouts in the
groups compared in Figure 5 (data not shown).
Figure 5. Harmaline tremor response in the BMT-treated animals. Averaged power
spectra of various groups treated with harmaline (A). The averaged power spectrum of
WtH group (solid gray line) appears different compared to the averaged power spectrum of
the other groups in (A). The averaged power spectra of the BmtWtH (solid black line),
TwiH (dashed black line), and BmtTwiH (solid gray line) appear very similar to each
other. The center frequency (B) and the bandwidth (C) were significantly increased in the
BmtWtH group (open triangles) compared to the WtH group (filled squares). The peak
power (D) was significantly decreased in the BmtWtH group compared to the WtH group.
There was no significant difference in center frequency, bandwidth or peak power between
the TwiH (open circles) and BmtTwiH groups (cross marks). Horizontal bars represent the
mean and the error bars represent the SEM (*** p < 0.001, ** p < 0.01 and * p < 0.05).
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3.4. Cerebellar Pathology
The brains of the various treatment groups were evaluated for the presence of globoid cells
(multinucleated macrophages with storage material) and myelination using Periodic acid-Schiff (PAS)
and Luxol fast blue (LFB) staining, respectively (Figure 6). When stained for PAS, the cerebellar
white matter from a Wt mouse shows no globoid cells (Figure 6A), in contrast the brain from a Twi
mouse contains a large number of multinucleate cells with pink staining cytoplasm (Figure 6B,
arrowheads). There is no apparent decrease in the number of globoid cells in the BmtTwi mouse
compared to the Twi mouse (Figure 6C). When the brains are stained for LFB, the Wt group shows
uniform myelination in the cerebellar white matter (asterisk in Figure 6D). In contrast, the architecture
of the myelin in the Twi group appears less well organized, probably secondary to inflammatory
edema (Figure 6E). In the BmtTwi group, the myelin remains disorganized, similar to that observed in
the Twi group (Figure 6F).
Figure 6. Histology—PAS and LFB staining. There are no identifiable PAS-positive
cells in the cerebellum of the Wt animal (A). In the Twi (B), there are numerous pink
multinucleated globoid cells (arrowheads). There is no obvious decrease in the number of
PAS-positive cells in the BmtTwi group (C). Comparison of LFB staining in the cerebellar
white matter (asterisk in D–F) and cerebellar folia shows a disruption of myelin
architecture (blue staining) in the Twi (E) mouse compared to the Wt (D) animal. In the
BmtTwi group (F), the myelin architecture remains disrupted, similar to the Twi group.

4. Discussion
In the current study, a detailed quantitative characterization of the tremor phenotype
(movement-related force oscillations) in the twitcher mice was performed using a force-plate
actometer. The tremor in the twitcher mouse was seen as increased power at relatively higher
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frequencies with a broader bandwidth than the movement-related force oscillations exhibited by the
wildtype mice moving normally on the force plate. An incidental finding in these studies was that the
stereotypical tremor produced by harmaline was significantly altered in the twitcher mice. Harmaline
is believed to disrupt the olivocereballar circuits [11]. The altered response of twitcher mice to
harmaline is consistent with the deficiency of GALC leading to inflammation and demyelination in the
white matter tracts of the cerebellum [12,13] including the olivocerebellar nucleus.
The validity of tremor monitoring in evaluating the effects of various therapies was also
determined. Hematopoietic stem cell transplantation (either using umbilical cord blood or bone
marrow) is the only available therapy for Krabbe’s disease in humans [14,15]. Bone marrow
transplantation also prolongs the lifespan in the twitcher mouse [12,16,17]. However, the effect of
radiation conditioning (in preparation for BMT) and transplantation of donor bone marrow cells on the
prominent tremor phenotype exhibited by the twitcher mouse had not heretofore been determined.
Twitcher mice receiving BMT had power spectra that had greater power in higher frequencies,
implying a worsening of tremor. This is contradictory to what is observed in terms of other measures
like lifespan seen in previous studies [12,13]. Interestingly, wildtype animals receiving only BMT also
had altered power spectra and were resistant to the effects of harmaline compared to the wildtype
animals that did not receive BMT. Bone marrow transplantation using myeloreductive conditioning
(400 rads of total body irradiation) is known to cause cerebellar dysplasia in neonatal mice [18]. The
blunted response of the harmaline-treated animals receiving BMT is also consistent with the
conditioning regimen causing cerebellar damage, including the olivocerebellar nucleus. Conditioning
and BMT could also be adversely affecting some as yet unknown regions in the brain or periphery to
give the same abnormal response. The current study thus highlights a possible harmful effect of
conditioning in treating the disease. These effects could be explained by the presence of rapidly
proliferating cells in the cerebellum during the time of conditioning and BMT [19]. Although, the
current study uses myeloreductive conditioning at post natal day 3 or 4, similar and perhaps more
severe function-compromising effects could be expected in studies that use fully myeloablative
regimens [16,17]. Although conditioning regimens used in newborn children [15] typically do not
involve ionizing radiation, the myeloablative drugs are nonetheless highly toxic and may superimpose
additional abnormal phenotypes on the already complex Krabbe’s disease presentation. This could
further complicate the interpretation of the therapeutic benefits of BMT for GLD.
This study establishes the use of a custom-built, ultra-sensitive force-plate actometer in evaluating
the effects of various therapies for the twitcher mice. It also emphasizes the need to evaluate the
impact of various therapeutic approaches on a wide variety of functions before drawing conclusions on
their safety and efficacy.
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